Comparative pre-clinical evaluation of resveratrol and 3,4,5,4'-tetramethoxystilbene (DMU212) as colorectal cancer chemopreventive agents
Recently a variety of analogues of resveratrol have been synthesised and investigated in in vivo assays. One analogue, 3,4,5,4'-tetramethoxystilbene (DMU212), showed preferential growth-inhibitory and pro-apoptotic properties in transformed cells, when compared with their untransformed counterp...
Main Author: | Sale, Stewart |
---|---|
Published: |
University of Leicester
2005
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.422845 |
Similar Items
-
The Effect of 3′-Hydroxy-3,4,5,4′-Tetramethoxy -stilbene, the Metabolite of the Resveratrol Analogue DMU-212, on the Motility and Proliferation of Ovarian Cancer Cells
by: Andrzej Nowicki, et al.
Published: (2020-02-01) -
Chemopreventive effect of resveratrol in preclinical colorectal cancer models with different genetic drivers
by: Jawad, Dhafer Sahib
Published: (2017) -
The Effect of 4′-hydroxy-3,4,5-trimetoxystilbene, the Metabolite of Resveratrol Analogue DMU-212, on Growth, Cell Cycle and Apoptosis in DLD-1 and LOVO Colon Cancer Cell Lines
by: Malgorzata Jozkowiak, et al.
Published: (2020-05-01) -
trans-3,3′,4,5′-Tetramethoxystilbene
by: Ri-An Yan, et al.
Published: (2011-08-01) -
An investigation into colorectal cancer chemopreventive mechanisms of 3', 4', 5', 5, 7-pentamethoxyflavone (PMF)
by: Fong, Isabel Lim
Published: (2012)